Sander A.J. Damen

Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)

Giuseppe De Luca, Sander A.J. Damen, Cyril Camaro et al. · EuroIntervention · 2019 · 185 citations

Medicine, Cardiology, Pharmacotherapy +17

Cardiac catheterization and intervention in haemophilia patients: prospective evaluation of the 2009 institutional guideline

A. Tuinenburg, Sander A.J. Damen, Paula F. Ypma et al. · Haemophilia · 2013 · 33 citations · Full text

Medicine, Cardiology, Hematology +17

Cardiac Troponin Composition Characterization after Non ST-Elevation Myocardial Infarction: Relation with Culprit Artery, Ischemic Time Window, and Severity of Injury

Sander A.J. Damen, G. Etienne Cramer, Hendrik-Jan Dieker et al. · Clinical Chemistry · 2020 · 24 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Multi‐Site Coronary Vein Sampling Study on Cardiac Troponin T Degradation in Non–ST‐Segment–Elevation Myocardial Infarction: Toward a More Specific Cardiac Troponin T Assay

Sander A.J. Damen, Wim H M Vroemen, Marc A. Brouwer et al. · Journal of the American Heart Association · 2019 · 23 citations · Full text

Medicine, Cardiology, Cardiac Nuclear Medicine +15

Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial

Cyril Camaro, Sander A.J. Damen, Marc A. Brouwer et al. · American Heart Journal · 2016 · 22 citations

Medicine, Cardiology, Pharmacotherapy +17